Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

This study evaluates a surgical approach called hybrid coronary revascularization (HCR) — a combination of minimally invasive bypass surgery and angioplasty (stenting) — for patients with blockages in multiple coronary arteries. Traditional bypass surgery (CABG) is very effective but involves opening the chest; HCR combines the best of bypass surgery (for the most important artery, the left anterior descending artery) with stenting for other blocked arteries, potentially offering excellent outcomes with less trauma. The study gathers real-world data on safety and effectiveness to help establish whether HCR is a reliable option for patients with multivessel coronary artery disease. You may be eligible if: - You are 20 years or older - You are undergoing hybrid coronary revascularization for blockages in multiple heart arteries (including the left anterior descending artery) - You have provided written consent You may NOT be eligible if: - You have previously had bypass surgery (CABG) - Your life expectancy is 1 year or less Talk to your doctor to see if this trial is right for you.